ViewRay (NASDAQ:VRAY – Get Rating) and CONMED (NASDAQ:CNMD – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Volatility and Risk
ViewRay has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for ViewRay and CONMED, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ViewRay | 0 | 6 | 1 | 0 | 2.14 |
| CONMED | 0 | 0 | 0 | 0 | N/A |
Valuation & Earnings
This table compares ViewRay and CONMED’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ViewRay | $102.21 million | 1.12 | -$107.33 million | ($0.60) | -1.04 |
| CONMED | $1.10 billion | 3.32 | -$80.58 million | ($3.25) | -36.70 |
CONMED has higher revenue and earnings than ViewRay. CONMED is trading at a lower price-to-earnings ratio than ViewRay, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares ViewRay and CONMED’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ViewRay | -105.01% | -93.57% | -38.79% |
| CONMED | -8.53% | 11.38% | 3.66% |
Insider & Institutional Ownership
84.4% of ViewRay shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 7.6% of CONMED shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary
CONMED beats ViewRay on 8 of the 13 factors compared between the two stocks.
About ViewRay
ViewRay, Inc. designs, manufactures, and markets the MRIdian MRI-guided Radiation Therapy System. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.
About CONMED
CONMED Corp. operates as a medical technology company, which engages in the development, manufacturing, and sale of surgical devices and related equipment. It operates through the United States, Europe, Middle East, and Africa, and Asia Pacific geographical segments. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
Receive News & Ratings for ViewRay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay and related companies with MarketBeat.com's FREE daily email newsletter.
